Management
Darren Head, President and Chief Executive Officer
Darren Head has 18 successful years of experience in biological, device and drug manufacturing operations, most recently leading Immucor Inc. While at Immucor he served as Vice President of Worldwide Operations as he directed commercial activities for all global operations. He previously headed Aronex Pharmaceuticals manufacturing and clinical supply operations in late Phase 3 programs. He was instrumental in preparing CMC sections for two NDA submissions. Prior to joining Aronex, Darren was Senior Director of Operations for Allergan Inc. He also proudly served in the United States Air Force. He holds a BS in Biology and completed most class work for a MBA from Texas A&M.
John Lightholder, MS, Vice President Process Development
Mr. Lightholder has over 30 years of experience in process development and production of biotherapeutics. Before joining Cytovance, Mr. Lightholder most recently served as Director of Process Development at Genzyme, where he managed and developed purification procedures for multi-subunit recombinant enzymes and monoclonal antibodies. Previously, he held the same position at Collagenesis, designing and enhancing production methods for dermal matrix products. Prior to Collagenesis, Mr. Lightholder was Director of Purification Development at Creative BioMolecules, culminating twelve years managing nearly every aspect of development and production of multiple therapeutic products. Previously he spent 15 years as a research associate and scientist at Damon Biotech, Tufts-New England Medical Center, The Salk Institute, Stanford University Medical Center, New England Deaconess Hospital, and the University of Massachusetts. He holds B.S. and M.S. degrees in Microbiology from the University of Massachusetts.
Debra Greiner-Powell, Vice President Quality Systems
Ms. Greiner-Powell has over 20 years of experience in the pharmaceutical/biotech industry. She leads the team that has developed and oversees the entire Quality function for GMP manufacturing at Cytovance Biologics. Prior to Cytovance, she was Manager of Quality Control at Genzyme Corporation, where she established the QC function for GMP manufacturing in the company’s Oklahoma City facility. Previously she served as Pharmaceutical Operations Management Advisor for Yamanouchi Pharma Technologies. Over a period of 10 years at Yamanouchi, she served in QC roles and managed teams involved in all aspects of pharmaceutical manufacturing for commercial OTC and prescription drug products. Prior to Yamanouchi, she was an ASCP registered Medical Technologist in several hospitals and laboratories in the Oklahoma City area. Ms. Greiner-Powell holds a B.S. in Microbiology from Oklahoma State University.
Molly S. McGlaughlin, Vice President Sales and Business Development
Molly McGlaughlin has 16 successful years of experience in Marketing and Business Development most recently leading Avecia Biotechnology Mammalian Cell Culture division. While at Avecia she led commercial activities for their synthetic DNA/siRNA , Peptide, and Microbial based products working on 30 plus customer programs. She previously headed Patheon’s expansion into the North American prescription market as a Senior Business Development Manager. Prior to joining Patheon Molly was a Senior Technical Representative and Director of Sales Training at Mallinckrodt Baker Inc.(now Tyco Healthcare). She is a highly decorated Operation Iraqi Freedom Veteran with extensive leadership experience. She holds a BS in Biology and MeD in Adult Education and Organizational Performance.